|
[1]
|
Wu, S.M., et al. (2019) Stroke in China: Advances and Challenges in Epidemiology, Prevention, and Management. The Lancet Neurology, 18, 394-405.
|
|
[2]
|
Jander, S., et al. (2001) Expression of Tissue Factor in High-Grade Carotid Artery Stenosis: Association with Plaque Destabilization. Stroke, 32, 850-854. [Google Scholar] [CrossRef]
|
|
[3]
|
Goldstein, L.B., et al. (2001) Primary Prevention of Ischemic Stroke: A Statement for Healthcare Professionals from the Stroke Council of the American Heart Association. Circulation, 103, 163-182. [Google Scholar] [CrossRef]
|
|
[4]
|
Wali, U., et al. (2019) Comparison of Serum Levels of Cystatin-C and Traditional Renal Biomarkers for the Early Detection of Pre-Hypertensive Nephropathy. The Journal of the Pakistan Medical Association, 69, 313-319.
|
|
[5]
|
Urbonaviciene, G., et al. (2011) Higher Cystatin C Level Predicts Long-Term Mortality in Patients with Peripheral Arterial Disease. Atherosclerosis, 216, 440-445. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Luo, J., et al. (2015) Cystatin C and Cardiovascular or All-Cause Mortality Risk in the General Population: A Meta-Analysis. Clinica Chimica Acta, 450, 39-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Doganer, Y.C., et al. (2013) Relationship of Cystatin C with Coronary Artery Disease and Its Severity. Coronary Artery Disease, 24, 119-126. [Google Scholar] [CrossRef]
|
|
[8]
|
Kaneko, R., et al. (2018) Serum Cystatin C Level Is Associated with Carotid Arterial Wall Elasticity in Subjects with Type 2 Diabetes Mellitus: A Potential Marker of Early-Stage Atherosclerosis. Diabetes Research and Clinical Practice, 139, 43-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
吴江, 杨弋, 饶明俐. 中国脑血管疾病分类2015 [J]. 中华神经科杂志, 2017, 50(3): 168-171.
|
|
[10]
|
Ren, J., Dong, X. and Nao, J. (2020) Serum Cystatin C Is Associated with Carotid Atherosclerosis in Patients with Acute Ischemic Stroke. Neurological Sciences. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
中华医学会外科学分会血管外科学组. 颈动脉狭窄诊治指南[J]. 中国血管外科杂志(电子版), 2017, 9(3): 169-175.
|
|
[12]
|
Saba, L., et al. (2009) Multidetector Row CT of the Brain and Carotid Artery: A Correlative Analysis. Clinical Radiology, 64, 767-778. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Randolph, S.A. (2016) Ischemic Stroke. Workplace Health & Safety, 64, 444. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Krasteva, M.P., et al. (2020) Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options. Advances in Therapy, 37, 1829-1865. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Xu, Y., et al. (2015) Cystatin C Is a Disease-Associated Protein Subject to Multiple Regulation. Immunology and Cell Biology, 93, 442-451. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Fatemi, S., et al. (2019) Copeptin, B-Type Natriuretic Peptide and Cystatin C Are Associated with Incident Symptomatic PAD. Biomarkers, 24, 615-621. [Google Scholar] [CrossRef]
|
|
[17]
|
Zhang, Y. and Sun, L. (2017) Cystatin C in Cerebrovascular Disorders. Current Neurovascular Research, 14, 406-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
GP, S., et al. (1999) Cystatin C Deficiency in Human Atherosclerosis and Aortic Aneurysms. The Journal of Clinical Investigation, 104, 1191-1197. [Google Scholar] [CrossRef]
|
|
[19]
|
Salgado, J.V., Souza, F.L. and Salgado, B.J. (2013) How to Understand the Association between Cystatin C Levels and Cardiovascular Disease: Imbalance, Counterbalance, or Consequence? Journal of Cardiology, 62, 331-335. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lafarge, J.C., et al. (2010) Cathepsins and Cystatin C in Atherosclerosis and Obesity. Biochimie, 92, 1580-1586. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Li, W., et al. (2016) Autophagy Dysfunction and Regulatory Cystatin C in Macrophage Death of Atherosclerosis. Journal of Cellular and Molecular Medicine, 20, 1664-1672. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Bengtsson, E., et al. (2005) Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2151-2156. [Google Scholar] [CrossRef]
|
|
[23]
|
陈艳, 等. 血清胱抑素C、同型半胱氨酸与颈动脉不稳定斑块相关性的研究进展[J]. 中国当代医药, 2020, 27(1): 24-27.
|
|
[24]
|
Yang, B., et al. (2015) Cystatin C Is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke. Neurotoxicity Research, 28, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Wang, Y., et al. (2019) Association between Cystatin C and the Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of Molecular Neuroscience, 69, 444-449. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Huang, G.X., et al. (2016) Association between Serum Cystatin C Levels and the Severity or Potential Risk Factors of Acute Ischemic Stroke. Neurological Research, 38, 518-523. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Yang, S., et al., (2016) Association between Serum Cystatin C Level and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients with Acute Lacunar Stroke. Journal of Stroke and Cerebrovascular Diseases, 26, 186-191. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Fang, Z., et al. (2019) Neuroprotective Autophagic Flux Induced by Hyperbaric Oxygen Preconditioning Is Mediated by Cystatin C. Neuroscience Bulletin, 35, 336-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wang, Y., et al. (2019) Determination of Clinical Cut-Off Values for Serum Cystatin C Levels to Predict Ischemic Stroke Risk. Journal of Stroke and Cerebrovascular Diseases, 28, Article ID: 104345. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Dong, X. and Nao, J. (2019) Cystatin C as an Index of Acute Cerebral Infraction Recurrence: One-Year Follow-Up Study. International Journal of Neuroscience, 129, 36-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Fang, Z., et al. (2017) Cystatin C Is a Crucial Endogenous Protective Determinant against Stroke. Stroke, 48, 436-444. [Google Scholar] [CrossRef]
|